Literature DB >> 8026274

Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol.

N Tanno1, S Oikawa, M Koizumi, H Kotake, H Hirakawa, Y Kanazawa, T Toyota.   

Abstract

The lipid composition of fasting duodenal bile was determined in 11 healthy subjects with normolipidemia and 15 patients with heterozygous familial hypercholesterolemia (FH) (12 with type IIa, three with type IIb). The age distribution among the groups of subjects was similar. In the patients with heterozygous FH type IIa, the mean value for molar percentage of cholesterol and lithogenic index (LI) of bile were significantly higher than those of controls (8.4 +/- 1.0%, 1.47 +/- 0.18 calculated by Hegard, Dam, and Holzbach vs 4.3 +/- 0.4%, 0.81 +/- 0.07, respectively). The value of LI in the patients with FH type IIb was also found to be significantly higher than that of the controls. In the patients with heterozygous FH type IIa, we observed both a significant decrease in the molar percentages of glycochenodeoxycholic acid, glycoursodeoxycholic acid, and glycolithocholic acid, and a significant increase of taurochenodeoxycholic acid compared to the corresponding values in the controls. Bile analysis of six patients was reexamined during probucol treatment after 16 weeks. Probucol significantly lowered serum cholesterol levels. However, biliary lipid composition and individual bile acid proportions was not altered by the treatment. The results suggest that most of the patients with heterozygous FH have supersaturated bile and are predisposed to cholesterol gallstone formation. In addition, the mechanism by which probucol lowers serum cholesterol appears to be independent of any change in the metabolism of biliary lipid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026274     DOI: 10.1007/bf02088069

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Effect of pravastatin on biliary lipid composition and bile acid synthesis in familial hypercholesterolaemia.

Authors:  N Hoogerbrugge-vd Linden; F W de Rooy; H Jansen; M van Blankenstein
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

2.  Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.

Authors:  P J Thomas; A F Hofmann
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

3.  Quantitative determination of serum triglycerides by the use of enzymes.

Authors:  G Bucolo; H David
Journal:  Clin Chem       Date:  1973-05       Impact factor: 8.327

Review 4.  Hepatic catabolism of low density lipoprotein: mechanisms and metabolic consequences.

Authors:  A D Attie; R C Pittman; D Steinberg
Journal:  Hepatology       Date:  1982 Mar-Apr       Impact factor: 17.425

Review 5.  Lipoprotein receptors and cholesterol homeostasis.

Authors:  R W Mahley; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1983-05-24

6.  The synthesis of taurocholic and glycocholic acids by preparations of human liver. I. Distribution of activity between subcellular fractions.

Authors:  T Scherstén
Journal:  Biochim Biophys Acta       Date:  1967-06-13

7.  Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate.

Authors:  O Leiss; K Meyer-Krahmer; K von Bergmann
Journal:  J Lipid Res       Date:  1986-07       Impact factor: 5.922

8.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man.

Authors:  R T Holzbach; M Marsh; M Olszewski; K Holan
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

9.  Role of cholesterol synthesis in regulation of bile acid synthesis and biliary cholesterol secretion in humans.

Authors:  J C Mitchell; B G Stone; G M Logan; W C Duane
Journal:  J Lipid Res       Date:  1991-07       Impact factor: 5.922

10.  Expression of the familial hypercholesterolemia gene in heterozygotes: mechanism for a dominant disorder in man.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1974-07-05       Impact factor: 47.728

View more
  2 in total

1.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

2.  Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.

Authors:  Ning Ma; Xiwang Liu; Xiaojun Kong; Shihong Li; Zenghua Jiao; Zhe Qin; Pengcheng Dong; Yajun Yang; Jianyong Li
Journal:  Lipids Health Dis       Date:  2017-12-11       Impact factor: 3.876

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.